NCT04626583View on ClinicalTrials.gov

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

April 21, 2023

Study Completion Date

April 21, 2023

Conditions
Mesenchymal Stromal CellsCorneaSafetyCorneal Defect
Interventions
BIOLOGICAL

Allogeneic MSC

Subconjunctival Injection of Allogeneic Mesenchymal Stromal Cells

Trial Locations (4)

19104

University of Pennsylvania Scheie Eye Institute, Philadelphia

21201

University of Maryland, Baltimore

60612

University of Illinois, Department of Ophthalmology and Visual Sciences, Chicago

02114

Mass Eye and Ear Institute, Boston

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Illinois at Chicago

OTHER

NCT04626583 - Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells | Biotech Hunter | Biotech Hunter